Detection and measurement of hypercholesterolaemia in South Africans attending general practitioners in private practice - The cholesterol monitor

South African Medical Journal

Volumn 88, Issue 12, 1998, Pages 1569-1574

  Steyn, K ^b   Fourie, J M ^b   Shepherd, J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; COLESTYRAMINE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PRIVATE PRACTICE; RISK FACTOR; SMOKING; SOUTH AFRICA;

ADULT; AGED; CHOLESTEROL, DIETARY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PRIVATE PRACTICE; RISK FACTORS; SOUTH AFRICA;

EID: 0032435280     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendation of the European Atherosclerosis Society. Nutr Metab Cardiovascular Dis 1992; 2: 113-156.
2. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Summary of the second report of the National Cholesterol Education Programme (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment panel 11). JAMA 1993; 269: 3015-3023.
3. Canadian Lipoprotein Conference ad hoc Committee on Guidelines for Dyslipoproteinemias. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Can Med Assoc J 1990; 142: 1371-1382.
4. Scientific Committee of the National Heart Foundation of New Zealand. Guidelines for detection and management of dyslipidaemia. N Z Med J 1993; 106: 133-141.
5. Steyn K, Fourie J, Bradshaw D. The impact of chronic diseases of lifestyle and their major risk factors on mortality in South Africa. S Afr Med J 1992; 82: 227-231.
6. Rossouw JE, Steyn K, Berger GMB, et al. Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa. S Afr Med J 1988; 73: 693-700.
7. Shepherd J, Pratt M. Prevention of coronary heart disease in clinical practice: A commentary on current treatment patterns in six European countries in relation to published recommendations. Cardiology 1996; 86: 1-5.
8. Clarke KW, Gray D, Keating NA, Hampton JR. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309: 563-566.
9. Volmink J, Laubscher J, Furman S. The SASPEN primary care survey - who consults the family doctor? S Afr Med J 1996; 86: 241-245.
10. Jackson WPU, Vinik AI, Joffe BI, et al. Prevalence of diabetes, glycosuria and related variables among the white population in Cape Town. S Afr Med J 1971; 45: 1496-1499.
11. Rossouw JE, Du Plessis JP, Benadé AJS, et al. Coronary risk factor screening in three rural communities: The CORIS baseline study. S Afr Med J 1983; 64: 430-436.
12. Reddy P, Meyer-Weitz A, Yach D. Smoking status, knowledge of health effects and attitudes in South Africa. S Afr Med J 1996; 86: 1389-1393.
13. Steyn K, Goldberg YP, Kotze MJ, et al. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum Genet 1996; 98: 479-484.
14. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995; 345: 1274-1275.
15. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323: 1112-1119.
16. Nawrocki JW, Weiss SR, Davidson MH, et al. Reduction of LDL-cholesterol by 60% in patients with primary hypercholesterolaemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 1995; 15: 678-682.
17. Poulter N. The coronary heart disease epidemic. In: Poulter N, Sever P, Thom S, eds. Cardiovascular Disease: Risk Factors and Intervention. Oxford: Radcliffe Medical Press, 1993.
18. Report of the Registrar General for Scotland. Edinburgh: HMSO, 1994.
19. Gillum RF. Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1993; 23: 1273-1277.